COVID-19 mRNA vaccine-mediated antibodies in human breast milk and their association with breast milk microbiota composition/Experiment 3

From BugSigDB


Reviewed Marked as Reviewed by ChiomaBlessing on 2024-2-15

Curated date: 2023/10/22

Curator: Folakunmi

Revision editor(s): Folakunmi, ChiomaBlessing

Subjects

Location of subjects
China
Host species Species from which microbiome was sampled. Contact us to have more species added.
Homo sapiens
Body site Anatomical site where microbial samples were extracted from according to the Uber Anatomy Ontology
Breast , Milk Mamma,Mammary part of chest,Mammary region,Breast,breast,Mammary gland milk,Milk,milk
Condition The experimental condition / phenotype studied according to the Experimental Factor Ontology
Response to vaccine Response to vaccine,response to vaccine
Group 0 name Corresponds to the control (unexposed) group for case-control studies
Low IgA mothers at one week post-second dose
Group 1 name Corresponds to the case (exposed) group for case-control studies
High IgA mothers at one week post-second dose
Group 1 definition Diagnostic criteria applied to define the specific condition / phenotype represented in the case (exposed) group
Breastfeeding mothers with high IgA at one week after receiving the second dose of the SARS-CoV-2 mRNA vaccine (BNT162b2).
Group 0 sample size Number of subjects in the control (unexposed) group
25
Group 1 sample size Number of subjects in the case (exposed) group
18
Antibiotics exclusion Number of days without antibiotics usage (if applicable) and other antibiotics-related criteria used to exclude participants (if any)
None

Lab analysis

Sequencing type
16S
16S variable region One or more hypervariable region(s) of the bacterial 16S gene
V3-V4
Sequencing platform Manufacturer and experimental platform used for quantifying microbial abundance
Illumina

Statistical Analysis

Data transformation Data transformation applied to microbial abundance measurements prior to differential abundance testing (if any).
relative abundances
Statistical test
LEfSe
Significance threshold p-value or FDR threshold used for differential abundance testing (if any)
0.004
MHT correction Have statistical tests be corrected for multiple hypothesis testing (MHT)?
No
LDA Score above Threshold for the linear discriminant analysis (LDA) score for studies using the popular LEfSe tool
2

Alpha Diversity

Shannon Estimator of species richness and species evenness: more weight on species richness
unchanged
Chao1 Abundance-based estimator of species richness
unchanged

Signature 1

Reviewed Marked as Reviewed by ChiomaBlessing on 2024-2-15

Curated date: 2023/10/22

Curator: Folakunmi

Revision editor(s): Folakunmi, ChiomaBlessing

Source: Figure 3d

Description: Taxonomic differences in microbiota one week post-second dose between high- and low-IgA subjects

Abundance in Group 1: increased abundance in High IgA mothers at one week post-second dose

NCBI Quality ControlLinks
Bifidobacterium bifidum
Candidatus Marinarcus aquaticus
Streptococcus parasuis
unclassified Acidaminococcus
unclassified Bifidobacterium
unclassified Corynebacterium
unclassified Dorea
unclassified Eubacterium
unclassified Gemmobacter
unclassified Holdemanella
unclassified Leucobacter
unclassified Neptunomonas
unclassified Rhodobacter
unclassified Subdoligranulum
unclassified Vibrio

Revision editor(s): Folakunmi, ChiomaBlessing

Signature 2

Reviewed Marked as Reviewed by ChiomaBlessing on 2024-2-15

Curated date: 2024/02/15

Curator: ChiomaBlessing

Revision editor(s): ChiomaBlessing

Source: Figure 3d

Description: Taxonomic differences in microbiota one week post-second dose between high- and low-IgA subjects

Abundance in Group 1: decreased abundance in High IgA mothers at one week post-second dose

NCBI Quality ControlLinks
Acinetobacter soli
unclassified Brevundimonas

Revision editor(s): ChiomaBlessing